Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-10-19 Sale | 2021-10-20 4:05 pm | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks | 3,759 | $3.19 | $11,991 | 46,241 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-05 Option Award | 2024-03-07 7:02 pm | N/A N/A | Innoviva Inc. | INVA | Ronsheim Matthew See Remarks | 12,768 | $14.88 | 161,216 (Direct) | View |
| 2024-03-05 Option Award | 2024-03-07 7:02 pm | 2025-02-20 2034-03-05 | Innoviva Inc. | INVA | Ronsheim Matthew See Remarks | 27,338 | $0 | 161,216 (Direct) | View |
| 2024-02-20 Tax Withholding | 2024-02-22 9:31 pm | N/A N/A | Innoviva Inc. | INVA | Ronsheim Matthew See Remarks | 807 | $15.8 | 28,010 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-22 9:16 pm | 2025-02-20 2034-01-17 | Innoviva Inc. | INVA | Ronsheim Matthew See Remarks | 60,000 | $0 | 121,917 (Direct) | View |
| 2024-01-18 Tax Withholding | 2024-01-22 9:16 pm | N/A N/A | Innoviva Inc. | INVA | Ronsheim Matthew See Remarks | 1,600 | $16.05 | 121,917 (Direct) | View |
Ownership | 2024-01-10 8:26 pm | N/A N/A | Innoviva Inc. | INVA | Ronsheim Matthew See Remarks | 0 | $0 | 63,517 (Direct) | View |
| 2022-07-07 Equity Swap | 2022-07-11 4:09 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief of Pharma Sciences & MFG | 17,572 | $2.2 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:09 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief of Pharma Sciences & MFG | 150,000 | $0 | 0 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:09 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief of Pharma Sciences & MFG | 88,333 | $0 | 0 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:04 pm | N/A 2029-09-16 | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks | 40,000 | $0 | 33,333 (Direct) | View |
| 2021-07-16 Option Award | 2022-02-15 4:04 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks | 33,333 | $0 | 33,333 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:04 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks | 125,000 | $0 | 167,572 (Direct) | View |
| 2021-11-02 Tax Withholding | 2021-11-03 4:05 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief, Pharma Sciences & MFG. | 3,669 | $2.94 | 42,572 (Direct) | View |
| 2021-10-19 Option Award | 2021-10-20 4:05 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks | 25,000 | $0 | 46,241 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-19 4:09 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2020-09-11 4:33 pm | N/A 2029-09-16 | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks | 0 | $0 | 95,000 (Direct) | View |